Signaling by ROBO receptors (Homo sapiens)

From WikiPathways

Revision as of 11:30, 9 August 2017 by ReactomeTeam (Talk | contribs)
Jump to: navigation, search
4161812, 157, 11, 1711, 171616cytosolcytosolSLIT2(31-1529) SOS1 ROBO1 CAPRAC1 GTP ROBO1 UnidentifiedproteaseGPC1 GDP Heparan sulfate N-acetyl-alpha-D-glucosaminide PAK6 GPC1 NCK1,NCK2NCK1 SRGAP1 ARHGAP39 CAP2 GTP NICK:ROBO1:SLIT2:GPC1:HSPGRAC1 Heparan sulfate N-acetyl-alpha-D-glucosaminide CDC42:GTPEna/Vasp proteinsClasp:Abl:Robo1:Slit2:Glypican-1ENAH PAK1 NCK2 NCK2 ARHGAP39SRGAP1 SLIT2:GPC1:HSPGGPC1 ROBO1 GPC1 ROBO1 PAK5 ROBO2 ROBO1 Heparan sulfate N-acetyl-alpha-D-glucosaminide CLASP2 ROBO3-1 CDC42:GDPENAH PAK4 SLIT2(31-1529) ROBO3-1ABL1 GPC1 CAP:Abl:Robo1:Slit2:Glypican-1CLASPROBO2 PAK6 VASP PiABL1 PAK4 RHO GTPases activatePAKsPiROBO1:SLIT2:SrGAPGPC1 SRGAP3 PAK3 SLIT2(31-1529) Heparan sulfate N-acetyl-alpha-D-glucosaminide SOS2 ROBO1:SLIT2:GPC1:HSPGROBO1 RAC1:GTPNCK1 ABL2 Heparan sulfate N-acetyl-alpha-D-glucosaminide GPC1 ABL1 SOS1 ROBO1 SLIT2(31-1529) EVL ABL1 PAK2 CDC42 ATPABL2 GPC1 CAP2 GPC1:HSPGROBO1:SLIT2:ARHGAP39GPC1 ROBO1 SRGAP2 ROBO1 H2OABL2 GPC1 ROBO1,ROBO2:ROBO3A.1NCK1 Heparan sulfate N-acetyl-alpha-D-glucosaminide PAK2 NCK1 ROBO1 ROBO1ABL2 CDC42 EVL p-Y1073-ROBO1 PFN1 GPC1 ProfilinSOS:NCK:ROBO1:SLIT2:GPC1:HSPGSRGAP3 SOSGlypican-1:Slit2:Robo1:Ena/Vasp:ProfilinADPSLIT2(31-1529) GDPCAP1 VASP SLIT2(31-1121)ROBO1 CLASP2 VASP PFN1 CLASP1 PAK1 PAKSLIT2(31-1529) Heparan sulfate N-acetyl-alpha-D-glucosaminide GPC1 SLIT2(31-1529) ABL1 NCK2 PFN2 Heparan sulfate N-acetyl-alpha-D-glucosaminide Heparan sulfate N-acetyl-alpha-D-glucosaminide ROBO1 GPC1 Heparan sulfate N-acetyl-alpha-D-glucosaminide SLIT2(31-1529) GPC1 Heparan sulfate N-acetyl-alpha-D-glucosaminide Abl tyrosine kinasesSLIT2(1122-1529)SrGAPNCK2 SOS2 Heparan sulfate N-acetyl-alpha-D-glucosaminide SLIT2(31-1529) Abl:Robo1:Slit2:Glypican-1Glypican-1:Slit2:Robo1:Ena/Vasp proteinsABL2 ENAH SRGAP2 PAK5 ROBO1 Pak:Nck:Robo1:Slit2:GlypicanSLIT2(31-1529) H2OSLIT2(31-1529) SLIT2(31-1529) CAP1 GTPAbl:pRobo1:slit2:Glypican-1RAC1:GDPROBO1,ROBO2CLASP1 Heparan sulfate N-acetyl-alpha-D-glucosaminide SLIT2(31-1529) SLIT2(31-1529)Heparan sulfate N-acetyl-alpha-D-glucosaminide GDP EVL PFN2 PAK3 1-3, 5, 6, 8...


Description

The Roundabout (Robo) family encodes transmembrane receptors that regulate axonal guidance and cell migration. The major function of the Robo receptors is to mediate repulsion of the navigating growth cones. There are four human Robo homologues, Robo1, Robo2, Robo3 and Robo4. Most of the Robos have the similar ectodomain architecture as the cell adhesion molecules, five Ig domains followed by three FN3 repeats except for Robo4, it has 2Ig and 2FN3 repeats. The cytoplasmic domains of Robo receptors are in general poorly conserved. However, there are four short conserved cytoplasmic sequence motifs, named CC0-3, that serve as binding sites for adaptor proteins. The ligands for the human Robo receptors are the three Slit proteins Slit1, Slit2, and Slit3; all of the Slit proteins contain a tandem of four LRR (leucine rich repeat) domains at N terminus, termed D1 D4 followed by six EGF (epidermal growth factor)-like domains, a laminin G like domain (ALPS), three EGF-like domains, and a C-terminal cysteine knot domain. Most Slit proteins are cleaved within the EGF-like region by unknown proteases.

Slit protein binding modulates Robo interactions with the cytosolic adaptors. The cytoplasmic domain of Robo1 and Robo2 determines the repulsive responses of these receptors. Based on the studies from both invertebrate and vertebrate organisms its been inferred that Robo induces growth cone repulsion by controlling cytoskeletal dynamics via either Abelson kinase (Abl) and Enabled (Ena), or Rac activity.
View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 376176
Reactome-version 
Reactome version: 61
Reactome Author 
Reactome Author: Garapati, Phani Vijay

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Mire E, Mezzera C, Leyva-Díaz E, Paternain AV, Squarzoni P, Bluy L, Castillo-Paterna M, López MJ, Peregrín S, Tessier-Lavigne M, Garel S, Galcerán J, Lerma J, López-Bendito G.; ''Spontaneous activity regulates Robo1 transcription to mediate a switch in thalamocortical axon growth.''; PubMed Europe PMC Scholia
  2. Chan PM, Manser E.; ''PAKs in human disease.''; PubMed Europe PMC Scholia
  3. Leung T, Chen XQ, Manser E, Lim L.; ''The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton.''; PubMed Europe PMC Scholia
  4. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Mühlemann O.; ''Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors.''; PubMed Europe PMC Scholia
  5. Bhuvanagiri M, Schlitter AM, Hentze MW, Kulozik AE.; ''NMD: RNA biology meets human genetic medicine.''; PubMed Europe PMC Scholia
  6. Dutil EM, Toker A, Newton AC.; ''Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1).''; PubMed Europe PMC Scholia
  7. Round JE, Sun H.; ''The adaptor protein Nck2 mediates Slit1-induced changes in cortical neuron morphology.''; PubMed Europe PMC Scholia
  8. Conrad AH, Zhang Y, Tasheva ES, Conrad GW.; ''Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.''; PubMed Europe PMC Scholia
  9. Szczepanowska J.; ''Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.''; PubMed Europe PMC Scholia
  10. Chang YF, Imam JS, Wilkinson MF.; ''The nonsense-mediated decay RNA surveillance pathway.''; PubMed Europe PMC Scholia
  11. Li L, Liu S, Lei Y, Cheng Y, Yao C, Zhen X.; ''Robo3.1A suppresses slit-mediated repulsion by triggering degradation of Robo2.''; PubMed Europe PMC Scholia
  12. Prasad A, Qamri Z, Wu J, Ganju RK.; ''Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.''; PubMed Europe PMC Scholia
  13. Durand S, Lykke-Andersen J.; ''SnapShot: Nonsense-mediated mRNA decay.''; PubMed Europe PMC Scholia
  14. Blockus H, Chédotal A.; ''Slit-Robo signaling.''; PubMed Europe PMC Scholia
  15. Sumi T, Matsumoto K, Nakamura T.; ''Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase.''; PubMed Europe PMC Scholia
  16. Jaworski A, Tom I, Tong RK, Gildea HK, Koch AW, Gonzalez LC, Tessier-Lavigne M.; ''Operational redundancy in axon guidance through the multifunctional receptor Robo3 and its ligand NELL2.''; PubMed Europe PMC Scholia
  17. Wang KH, Brose K, Arnott D, Kidd T, Goodman CS, Henzel W, Tessier-Lavigne M.; ''Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching.''; PubMed Europe PMC Scholia
  18. Stalder L, Mühlemann O.; ''The meaning of nonsense.''; PubMed Europe PMC Scholia
  19. Wang J, Wu JW, Wang ZX.; ''Mechanistic studies of the autoactivation of PAK2: a two-step model of cis initiation followed by trans amplification.''; PubMed Europe PMC Scholia
  20. Samelson BK, Gore BB, Whiting JL, Nygren PJ, Purkey AM, Colledge M, Langeberg LK, Dell'Acqua ML, Zweifel LS, Scott JD.; ''A-kinase Anchoring Protein 79/150 Recruits Protein Kinase C to Phosphorylate Roundabout Receptors.''; PubMed Europe PMC Scholia
  21. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, Tessier-Lavigne M, Kidd T.; ''Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance.''; PubMed Europe PMC Scholia
  22. Jung JH, Traugh JA.; ''Regulation of the interaction of Pak2 with Cdc42 via autophosphorylation of serine 141.''; PubMed Europe PMC Scholia
  23. Amano M, Nakayama M, Kaibuchi K.; ''Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.''; PubMed Europe PMC Scholia
  24. Neu-Yilik G, Kulozik AE.; ''NMD: multitasking between mRNA surveillance and modulation of gene expression.''; PubMed Europe PMC Scholia
  25. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L.; ''A brain serine/threonine protein kinase activated by Cdc42 and Rac1.''; PubMed Europe PMC Scholia
  26. Zhang B, Dietrich UM, Geng JG, Bicknell R, Esko JD, Wang L.; ''Repulsive axon guidance molecule Slit3 is a novel angiogenic factor.''; PubMed Europe PMC Scholia
  27. Ypsilanti AR, Chedotal A.; ''Roundabout receptors.''; PubMed Europe PMC Scholia
  28. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K.; ''Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase).''; PubMed Europe PMC Scholia
  29. Zhang F, Ronca F, Linhardt RJ, Margolis RU.; ''Structural determinants of heparan sulfate interactions with Slit proteins.''; PubMed Europe PMC Scholia
  30. Hohenester E.; ''Structural insight into Slit-Robo signalling.''; PubMed Europe PMC Scholia
  31. Daniels RH, Bokoch GM.; ''p21-activated protein kinase: a crucial component of morphological signaling?''; PubMed Europe PMC Scholia
  32. Isken O, Maquat LE.; ''Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function.''; PubMed Europe PMC Scholia
  33. Bashaw GJ, Kidd T, Murray D, Pawson T, Goodman CS.; ''Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor.''; PubMed Europe PMC Scholia
  34. Piper M, Little M.; ''Movement through Slits: cellular migration via the Slit family.''; PubMed Europe PMC Scholia
  35. Graf B, Bähler M, Hilpelä P, Böwe C, Adam T.; ''Functional role for the class IX myosin myr5 in epithelial cell infection by Shigella flexneri.''; PubMed Europe PMC Scholia
  36. Kong R, Yi F, Wen P, Liu J, Chen X, Ren J, Li X, Shang Y, Nie Y, Wu K, Fan D, Zhu L, Feng W, Wu JY.; ''Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.''; PubMed Europe PMC Scholia
  37. Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
  38. Post PL, Bokoch GM, Mooseker MS.; ''Human myosin-IXb is a mechanochemically active motor and a GAP for rho.''; PubMed Europe PMC Scholia
  39. Rebbapragada I, Lykke-Andersen J.; ''Execution of nonsense-mediated mRNA decay: what defines a substrate?''; PubMed Europe PMC Scholia
  40. Zhang B, Chernoff J, Zheng Y.; ''Interaction of Rac1 with GTPase-activating proteins and putative effectors. A comparison with Cdc42 and RhoA.''; PubMed Europe PMC Scholia
  41. Borrell V, Cárdenas A, Ciceri G, Galcerán J, Flames N, Pla R, Nóbrega-Pereira S, García-Frigola C, Peregrín S, Zhao Z, Ma L, Tessier-Lavigne M, Marín O.; ''Slit/Robo signaling modulates the proliferation of central nervous system progenitors.''; PubMed Europe PMC Scholia
  42. Ronca F, Andersen JS, Paech V, Margolis RU.; ''Characterization of Slit protein interactions with glypican-1.''; PubMed Europe PMC Scholia
  43. Bravo-Ambrosio A, Mastick G, Kaprielian Z.; ''Motor axon exit from the mammalian spinal cord is controlled by the homeodomain protein Nkx2.9 via Robo-Slit signaling.''; PubMed Europe PMC Scholia
  44. Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
  45. Parrini MC, Lei M, Harrison SC, Mayer BJ.; ''Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.''; PubMed Europe PMC Scholia
  46. Zhao ZS, Manser E, Lim L.; ''Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation.''; PubMed Europe PMC Scholia
  47. Manser E, Chong C, Zhao ZS, Leung T, Michael G, Hall C, Lim L.; ''Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family.''; PubMed Europe PMC Scholia
  48. Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, Narumiya S.; ''The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase.''; PubMed Europe PMC Scholia
  49. Huang Z, Wen P, Kong R, Cheng H, Zhang B, Quan C, Bian Z, Chen M, Zhang Z, Chen X, Du X, Liu J, Zhu L, Fushimi K, Hua D, Wu JY.; ''USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.''; PubMed Europe PMC Scholia
  50. Keranen LM, Dutil EM, Newton AC.; ''Protein kinase C is regulated in vivo by three functionally distinct phosphorylations.''; PubMed Europe PMC Scholia
  51. Behm-Ansmant I, Kashima I, Rehwinkel J, Saulière J, Wittkopp N, Izaurralde E.; ''mRNA quality control: an ancient machinery recognizes and degrades mRNAs with nonsense codons.''; PubMed Europe PMC Scholia
  52. Yuasa-Kawada J, Kinoshita-Kawada M, Rao Y, Wu JY.; ''Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.''; PubMed Europe PMC Scholia
  53. Chong C, Tan L, Lim L, Manser E.; ''The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity.''; PubMed Europe PMC Scholia
  54. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K.; ''Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop.''; PubMed Europe PMC Scholia
  55. Kadlec J, Izaurralde E, Cusack S.; ''The structural basis for the interaction between nonsense-mediated mRNA decay factors UPF2 and UPF3.''; PubMed Europe PMC Scholia
  56. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K.; ''Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)''; PubMed Europe PMC Scholia
  57. Lei M, Lu W, Meng W, Parrini MC, Eck MJ, Mayer BJ, Harrison SC.; ''Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch.''; PubMed Europe PMC Scholia
  58. Watanabe T, Hosoya H, Yonemura S.; ''Regulation of myosin II dynamics by phosphorylation and dephosphorylation of its light chain in epithelial cells.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114743view16:23, 25 January 2021ReactomeTeamReactome version 75
113187view11:25, 2 November 2020ReactomeTeamReactome version 74
112415view15:35, 9 October 2020ReactomeTeamReactome version 73
101319view11:20, 1 November 2018ReactomeTeamreactome version 66
100856view20:53, 31 October 2018ReactomeTeamreactome version 65
100397view19:27, 31 October 2018ReactomeTeamreactome version 64
99945view16:11, 31 October 2018ReactomeTeamreactome version 63
99501view14:44, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
94032view13:52, 16 August 2017ReactomeTeamreactome version 61
93654view11:30, 9 August 2017ReactomeTeamreactome version 61
86772view09:26, 11 July 2016ReactomeTeamreactome version 56
83078view09:53, 18 November 2015ReactomeTeamVersion54
81399view12:55, 21 August 2015ReactomeTeamVersion53
76868view08:14, 17 July 2014ReactomeTeamFixed remaining interactions
76573view11:55, 16 July 2014ReactomeTeamFixed remaining interactions
75906view09:56, 11 June 2014ReactomeTeamRe-fixing comment source
75606view10:45, 10 June 2014ReactomeTeamReactome 48 Update
74961view13:48, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74605view08:39, 30 April 2014ReactomeTeamReactome46
68889view17:27, 8 July 2013MaintBotUpdated to 2013 gpml schema
45209view17:22, 7 October 2011KhanspersOntology Term : 'signaling pathway' added !
42134view21:59, 4 March 2011MaintBotAutomatic update
39944view05:57, 21 January 2011MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ABL1 ProteinP00519 (Uniprot-TrEMBL)
ABL2 ProteinP42684 (Uniprot-TrEMBL)
ADPMetaboliteCHEBI:16761 (ChEBI)
ARHGAP39 ProteinQ9C0H5 (Uniprot-TrEMBL)
ARHGAP39ProteinQ9C0H5 (Uniprot-TrEMBL)
ATPMetaboliteCHEBI:15422 (ChEBI)
Abl tyrosine kinasesComplexR-HSA-376002 (Reactome)
Abl:Robo1:Slit2:Glypican-1ComplexR-HSA-428873 (Reactome)
Abl:pRobo1:slit2:Glypican-1ComplexR-HSA-376027 (Reactome)
CAP1 ProteinQ01518 (Uniprot-TrEMBL)
CAP2 ProteinP40123 (Uniprot-TrEMBL)
CAP:Abl:Robo1:Slit2:Glypican-1ComplexR-HSA-428875 (Reactome)
CAPComplexR-HSA-428868 (Reactome)
CDC42 ProteinP60953 (Uniprot-TrEMBL)
CDC42:GDPComplexR-HSA-418830 (Reactome)
CDC42:GTPComplexR-HSA-182921 (Reactome)
CLASP1 ProteinQ7Z460 (Uniprot-TrEMBL)
CLASP2 ProteinO75122 (Uniprot-TrEMBL)
CLASPComplexR-HSA-428867 (Reactome)
Clasp:Abl:Robo1:Slit2:Glypican-1ComplexR-HSA-428876 (Reactome)
ENAH ProteinQ8N8S7 (Uniprot-TrEMBL)
EVL ProteinQ9UI08 (Uniprot-TrEMBL)
Ena/Vasp proteinsComplexR-HSA-428478 (Reactome)
GDP MetaboliteCHEBI:17552 (ChEBI)
GDPMetaboliteCHEBI:17552 (ChEBI)
GPC1 ProteinP35052 (Uniprot-TrEMBL)
GPC1:HSPGComplexR-HSA-428493 (Reactome)
GTP MetaboliteCHEBI:15996 (ChEBI)
GTPMetaboliteCHEBI:15996 (ChEBI)
Glypican-1:Slit2:Robo1:Ena/Vasp proteinsComplexR-HSA-376032 (Reactome)
Glypican-1:Slit2:Robo1:Ena/Vasp:ProfilinComplexR-HSA-428492 (Reactome)
H2OMetaboliteCHEBI:15377 (ChEBI)
Heparan sulfate N-acetyl-alpha-D-glucosaminide MetaboliteCHEBI:17421 (ChEBI)
NCK1 ProteinP16333 (Uniprot-TrEMBL)
NCK1,NCK2ComplexR-HSA-381949 (Reactome)
NCK2 ProteinO43639 (Uniprot-TrEMBL)
NICK:ROBO1:SLIT2:GPC1:HSPGComplexR-HSA-428486 (Reactome)
PAK1 ProteinQ13153 (Uniprot-TrEMBL)
PAK2 ProteinQ13177 (Uniprot-TrEMBL)
PAK3 ProteinO75914 (Uniprot-TrEMBL)
PAK4 ProteinO96013 (Uniprot-TrEMBL)
PAK5 ProteinQ9P286 (Uniprot-TrEMBL)
PAK6 ProteinQ9NQU5 (Uniprot-TrEMBL)
PAKComplexR-HSA-428475 (Reactome)
PFN1 ProteinP07737 (Uniprot-TrEMBL)
PFN2 ProteinP35080 (Uniprot-TrEMBL)
Pak:Nck:Robo1:Slit2:GlypicanComplexR-HSA-428482 (Reactome)
PiMetaboliteCHEBI:18367 (ChEBI)
ProfilinComplexR-HSA-203077 (Reactome)
RAC1 ProteinP63000 (Uniprot-TrEMBL)
RAC1:GDPComplexR-HSA-5674631 (Reactome)
RAC1:GTPComplexR-HSA-442641 (Reactome)
RHO GTPases activate PAKsPathwayR-HSA-5627123 (Reactome) The PAKs (p21-activated kinases) are a family of serine/threonine kinases mainly implicated in cytoskeletal rearrangements. All PAKs share a conserved catalytic domain located at the carboxyl terminus and a highly conserved motif in the amino terminus known as p21-binding domain (PBD) or Cdc42/Rac interactive binding (CRIB) domain. There are six mammalian PAKs that can be divided into two classes: class I (or conventional) PAKs (PAK1-3) and class II PAKs (PAK4-6). Conventional PAKs are important regulators of cytoskeletal dynamics and cell motility and are additionally implicated in transcription through MAPK (mitogen-activated protein kinase) cascades, death and survival signaling and cell cycle progression (Chan and Manser 2012).

PAK1, PAK2 and PAK3 are direct effectors of RAC1 and CDC42 GTPases. RAC1 and CDC42 bind to the CRIB domain. This binding induces a conformational change that disrupts inactive PAK homodimers and relieves autoinhibition of the catalytic carboxyl terminal domain (Manser et al. 1994, Manser et al. 1995, Zhang et al. 1998, Lei et al. 2000, Parrini et al. 2002; reviewed by Daniels and Bokoch 1999, Szczepanowska 2009). Autophosphorylation of a conserved threonine residue in the catalytic domain of PAKs (T423 in PAK1, T402 in PAK2 and T436 in PAK3) is necessary for the kinase activity of PAK1, PAK2 and PAK3. Autophosphorylation of PAK1 serine residue S144, PAK2 serine residue S141, and PAK3 serine residue S154 disrupts association of PAKs with RAC1 or CDC42 and enhances kinase activity (Lei et al. 2000, Chong et al. 2001, Parrini et al. 2002, Jung and Traugh 2005, Wang et al. 2011). LIMK1 is one of the downstream targets of PAK1 and is activated through PAK1-mediated phosphorylation of the threonine residue T508 within its activation loop (Edwards et al. 1999). Further targets are the myosin regulatory light chain (MRLC), myosin light chain kinase (MLCK), filamin, cortactin, p41Arc (a subunit of the Arp2/3 complex), caldesmon, paxillin and RhoGDI, to mention a few (Szczepanowska 2009).

Class II PAKs also have a CRIB domain, but lack a defined autoinhibitory domain and proline-rich regions. They do not require GTPases for their kinase activity, but their interaction with RAC or CDC42 affects their subcellular localization. Only conventional PAKs will be annotated here.

ROBO1 ProteinQ9Y6N7 (Uniprot-TrEMBL)
ROBO1,ROBO2:ROBO3A.1ComplexR-HSA-428496 (Reactome)
ROBO1,ROBO2ComplexR-HSA-428477 (Reactome)
ROBO1:SLIT2:ARHGAP39ComplexR-HSA-428491 (Reactome)
ROBO1:SLIT2:GPC1:HSPGComplexR-HSA-390371 (Reactome)
ROBO1:SLIT2:SrGAPComplexR-HSA-376031 (Reactome)
ROBO1ProteinQ9Y6N7 (Uniprot-TrEMBL)
ROBO2 ProteinQ9HCK4 (Uniprot-TrEMBL)
ROBO3-1 ProteinQ96MS0-1 (Uniprot-TrEMBL)
ROBO3-1ProteinQ96MS0-1 (Uniprot-TrEMBL)
SLIT2(1122-1529)ProteinO94813 (Uniprot-TrEMBL)
SLIT2(31-1121)ProteinO94813 (Uniprot-TrEMBL)
SLIT2(31-1529) ProteinO94813 (Uniprot-TrEMBL)
SLIT2(31-1529)ProteinO94813 (Uniprot-TrEMBL)
SLIT2:GPC1:HSPGComplexR-HSA-428489 (Reactome)
SOS1 ProteinQ07889 (Uniprot-TrEMBL)
SOS2 ProteinQ07890 (Uniprot-TrEMBL)
SOS:NCK:ROBO1:SLIT2:GPC1:HSPGComplexR-HSA-428481 (Reactome)
SOSComplexR-HSA-167215 (Reactome)
SRGAP1 ProteinQ7Z6B7 (Uniprot-TrEMBL)
SRGAP2 ProteinO75044 (Uniprot-TrEMBL)
SRGAP3 ProteinO43295 (Uniprot-TrEMBL)
SrGAPComplexR-HSA-428474 (Reactome)
Unidentified proteaseR-HSA-428470 (Reactome)
VASP ProteinP50552 (Uniprot-TrEMBL)
p-Y1073-ROBO1 ProteinQ9Y6N7 (Uniprot-TrEMBL)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
ADPArrowR-HSA-428888 (Reactome)
ARHGAP39R-HSA-428536 (Reactome)
ATPR-HSA-428888 (Reactome)
Abl tyrosine kinasesR-HSA-376141 (Reactome)
Abl:Robo1:Slit2:Glypican-1ArrowR-HSA-376141 (Reactome)
Abl:Robo1:Slit2:Glypican-1R-HSA-428883 (Reactome)
Abl:Robo1:Slit2:Glypican-1R-HSA-428885 (Reactome)
Abl:Robo1:Slit2:Glypican-1R-HSA-428888 (Reactome)
Abl:Robo1:Slit2:Glypican-1mim-catalysisR-HSA-428888 (Reactome)
Abl:pRobo1:slit2:Glypican-1ArrowR-HSA-428888 (Reactome)
CAP:Abl:Robo1:Slit2:Glypican-1ArrowR-HSA-428883 (Reactome)
CAPR-HSA-428883 (Reactome)
CDC42:GDPArrowR-HSA-428533 (Reactome)
CDC42:GTPR-HSA-428533 (Reactome)
CLASPR-HSA-428885 (Reactome)
Clasp:Abl:Robo1:Slit2:Glypican-1ArrowR-HSA-428885 (Reactome)
Ena/Vasp proteinsR-HSA-376140 (Reactome)
GDPArrowR-HSA-428535 (Reactome)
GPC1:HSPGR-HSA-428518 (Reactome)
GTPR-HSA-428535 (Reactome)
Glypican-1:Slit2:Robo1:Ena/Vasp proteinsArrowR-HSA-376140 (Reactome)
Glypican-1:Slit2:Robo1:Ena/Vasp proteinsR-HSA-428534 (Reactome)
Glypican-1:Slit2:Robo1:Ena/Vasp:ProfilinArrowR-HSA-428534 (Reactome)
H2OR-HSA-428522 (Reactome)
H2OR-HSA-428533 (Reactome)
NCK1,NCK2R-HSA-428511 (Reactome)
NICK:ROBO1:SLIT2:GPC1:HSPGArrowR-HSA-428511 (Reactome)
NICK:ROBO1:SLIT2:GPC1:HSPGR-HSA-428515 (Reactome)
NICK:ROBO1:SLIT2:GPC1:HSPGR-HSA-428531 (Reactome)
PAKR-HSA-428531 (Reactome)
Pak:Nck:Robo1:Slit2:GlypicanArrowR-HSA-428531 (Reactome)
PiArrowR-HSA-428522 (Reactome)
PiArrowR-HSA-428533 (Reactome)
ProfilinR-HSA-428534 (Reactome)
R-HSA-204364 (Reactome) The Slit family consists of three members that are all expressed in the ventral midline (floor plate) of the neural tube. Slit 1 is predominantly expressed in the nervous system whereas Slit 2 and 3 are also expressed outside the nervous system.
Slit proteins are the ligands for the Robo receptors. In humans there are four robo genes: Robo1, 2, 3 and 4. The extracellular domain of Robo comprises five Ig domains and three Fn domains except for Robo4 (2Ig+2Fn). Ig1 and Ig2 domains of Robo are highly conserved and are important for Slit binding. The concave face of slit's second LRR domain accommodates the Robo's Ig1 and 2 domains. Slit binding with Robo4 is controversial as the interaction is weak and its been observed using the in-vitro methods.

R-HSA-376140 (Reactome) Ena is required in part for Robo's repulsive output. Ena is drawn as an effector downstream of Robo signaling via a direct interaction with Robo. Robo's CC2 (LPPPP) motif is the consensus binding site for the EVH1 domain of Ena.
The Ena/VASP family of proteins has a universal role in control of cell motility and actin dynamics. These proteins consist of an N terminal EVH1 domain, a central proline rich region, which acts as a ligand for the actin monomer binding protein Profilin as well as several SH3 domain containing proteins including Abl and a C terminal EVH2 domain involved in oligomerization and F actin binding.

R-HSA-376141 (Reactome) Abl binds directly, via its SH3 domain, to the CC3 motif in the cytoplasmic domain of human Robo1.
R-HSA-376145 (Reactome) The Robo1 receptor regulates Rho GTPase activity through a ligand-dependent association with members of a novel family of GAPs called srGAPs (slit-robo GAPs). Extracellular interaction between Slit and Robo increases the intracellular interaction between the CC3 motif of Robo1 and the SH3 motif of the SrGAPs.
R-HSA-376149 (Reactome) The full length Slit proteins are membrane bound via the extracellular matrix proteins when not bound to Robo receptors. These full length Slits undergo post translational modification and proteolytic processing to generate an N terminal fragment (Slit2 N) and a corresponding C terminal fragment (Slit2 C). Slit 2 is cleaved within the EGF repeats, between EGF5 and EGF6, by unknown proteases. Cleavage of Slit proteins is evolutionarily conserved, although the molecular biological significance is unknown. The N-terminal fragment of Slit2 stimulates growth and branching of dorsal root ganglia (DRG) axons, and this activity is opposed by un-cleaved Slit. The stimulation of axon branching is mediated by Robo receptors. Additional functional differences between the full-length and N-terminal forms have been discovered in their abilities to repel different populations of axons and dendrites. Finally, Slit can attract migrating muscles in the fly, and also human endothelial cells, both via Robo receptors.
R-HSA-428510 (Reactome) Robo3 antagonizes Robo1/Robo2 function to prevent their response to slit, thus allowing cells that are expressing Robo1/Robo2 to progress towards and across the floor plate. Exactly how Robo3 interferes with Robo1/Robo2 function is not yet clear. One possibility is that one of the Robo3 isoform Robo3A.1 may sequester Robo1 into inactive receptor complexes. Robo3 in mouse and human have two isoforms, Robo3A.1 and Robo3A.2 with different Slit-binding activities. Both isoforms can form heterodimers with Robo1 and Robo2, but Robo3A.1 heterodimers cannot bind Slit, so this isoform may serve to sequester and inactivate Robo1.
R-HSA-428511 (Reactome) Slit stimulation recruits SH3 SH2 adaptor protein Dreadlocks (Dock) (Nck in vertebrates) to the Robo receptor.
R-HSA-428515 (Reactome) Upon SLIT-mediated ROBO stimulation, SOS1 or SOS2 is recruited into the multiprotein complex consisting of SLIT2, ROBO1 and the SH3-SH2 protein NCK1 or NCK2 (orthologues of Drosophila DOCK). NCK bridges the physical association between ROBO and SOS. This interaction was demonstrated in both Drosophila and human cells (Hu et al. 1995, Fritz et al. 2000, Yang and Bashaw 2006).
R-HSA-428518 (Reactome) Slit 2 and both its natural cleavage products bind glypican 1, a glycosyl phosphatidyl inositol (GPI) anchored heparan sulfate proteoglycan (HSPG) through its C terminus. Glypican 1 HSPG is important for high affinity binding of Slit to its receptor and for the repulsive activity of Slit. Slit-Robo signaling strictly requires binding to heparan sulfate. HSPGs may also modulate the extracellular distribution or stability of Slit proteins.
R-HSA-428522 (Reactome) Vilse and its human homolog bind directly to the intracellular domains of the corresponding Robo receptors and promote the hydrolysis of RacGTP.
R-HSA-428531 (Reactome) NCK1 or NCK2, orthologues of Drosophila Dock, bound to ROBO1 receptor recruits PAK to specific sites at the growth cone membrane, where PAK, activated by RAC1, regulates the recycling and retrograde flow of actin filaments. In mammals there are six PAK isoforms (PAK1-6) and PAK binds to the 2nd SH3 domain of NCK with its proline rich PxxP motif (Galisteo et al. 1996, Fan et al. 2003). PAK autophosphorylation triggered by RAC1/CDC42 activation disrupts PAK interaction with NCK proteins (Zhao et al. 2000).
R-HSA-428533 (Reactome) srGAP bound to Robo's cytoplasmic tail increase the intrinsic GTPase activity of Cdc42, which converts the GTP-bound form of Cdc42 into its GDP-bound form, therefore inactivating Cdc42. Inactivation of Cdc42 leads to a reduction in the activation of the Neuronal WiskottAldrich Syndrome protein (NWASP), thus decreasing the level of active Arp2/3 complex. Because active Arp2/3 promotes actin polymerization, the reduction of active Cdc42 eventually decreases actin polymerization. Slit regulates SrGAP interaction with Robo1 and Cdc42, it increases SrGAP interaction with Cdc42.
R-HSA-428534 (Reactome) Ena/VASP proteins enhance actin filament elongation via the recruitment of profilin:actin complexes to the tips of spreading lamellipodia. Profilin binds to the central proline rich domain of Ena/VASP protein.
R-HSA-428535 (Reactome) Sos bound to Dock/Nck, with its Rac GEF activity activates Rac. Son of sevenless (Sos) is a dual specificity guanine nucleotide exchange factor (GEF) that regulates both Ras and Rho family GTPases. The Ras and Rac-GEF activities of Sos can be uncoupled during Robo-mediated axon repulsion; Sos axon guidance function depends on its Rac-GEF activity, but not its Ras-GEF activity.
R-HSA-428536 (Reactome) Vilse/CrossGAP (CrGAP) a conserved Rac-Specific GAP in Drosophila is involved in Robo mediated repulsion. CrGAP directly binds to Robo both biochemically and genetically. This interaction is mediated by the WW domains in CrGAP and the CC2 motif of Robo.
The human homologue of Vilse/CrGAP, KIAA1688, was identified which shares 54.4% sequence similarity with Drosophila CrGAP and is referred as human Vilse/CrGAP protein.
R-HSA-428883 (Reactome) Abl associated with Robo1, Slit2, and glypican at the plasma membrane binds CAP and regulate its activity to inhibit net actin assembly. Studies of CAP homologs from yeast, Dictyostelium, mouse, pig, and human suggest that the C terminal actin binding domain acts to sequester monomers to prevent actin polymerization.
R-HSA-428885 (Reactome) CLASP acts positively downstream of Abl as part of the repellent response initiated by activation of Robo1. CLASP is spatially positioned to interact with Robo receptors. Slit mediated repulsion results in activation of CLASP, presumably through its phosphorylation by the Abl kinase. Activation of CLASP in turn results in inhibition of microtubule polymerization on the side of the growth cone receiving the repulsive signal and consequently the growth cone turns to the opposite side. A direct link between Abl and CLASP, notably the mechanism of CLASP activation, has not been demonstrated, however.
R-HSA-428888 (Reactome) Abl kinase phosphorylates the tyrosine residue (1073) of the conserved CC1 motif (PTPYATT) in human Robo1.
RAC1:GDPArrowR-HSA-428522 (Reactome)
RAC1:GDPR-HSA-428535 (Reactome)
RAC1:GTPArrowR-HSA-428535 (Reactome)
RAC1:GTPR-HSA-428522 (Reactome)
ROBO1,ROBO2:ROBO3A.1ArrowR-HSA-428510 (Reactome)
ROBO1,ROBO2R-HSA-428510 (Reactome)
ROBO1:SLIT2:ARHGAP39ArrowR-HSA-428536 (Reactome)
ROBO1:SLIT2:ARHGAP39mim-catalysisR-HSA-428522 (Reactome)
ROBO1:SLIT2:GPC1:HSPGArrowR-HSA-204364 (Reactome)
ROBO1:SLIT2:GPC1:HSPGR-HSA-376140 (Reactome)
ROBO1:SLIT2:GPC1:HSPGR-HSA-376141 (Reactome)
ROBO1:SLIT2:GPC1:HSPGR-HSA-376145 (Reactome)
ROBO1:SLIT2:GPC1:HSPGR-HSA-428511 (Reactome)
ROBO1:SLIT2:GPC1:HSPGR-HSA-428536 (Reactome)
ROBO1:SLIT2:SrGAPArrowR-HSA-376145 (Reactome)
ROBO1:SLIT2:SrGAPmim-catalysisR-HSA-428533 (Reactome)
ROBO1R-HSA-204364 (Reactome)
ROBO3-1R-HSA-428510 (Reactome)
SLIT2(1122-1529)ArrowR-HSA-376149 (Reactome)
SLIT2(31-1121)ArrowR-HSA-376149 (Reactome)
SLIT2(31-1529)R-HSA-376149 (Reactome)
SLIT2(31-1529)R-HSA-428518 (Reactome)
SLIT2:GPC1:HSPGArrowR-HSA-428518 (Reactome)
SLIT2:GPC1:HSPGR-HSA-204364 (Reactome)
SOS:NCK:ROBO1:SLIT2:GPC1:HSPGArrowR-HSA-428515 (Reactome)
SOS:NCK:ROBO1:SLIT2:GPC1:HSPGmim-catalysisR-HSA-428535 (Reactome)
SOSR-HSA-428515 (Reactome)
SrGAPR-HSA-376145 (Reactome)
Unidentified proteasemim-catalysisR-HSA-376149 (Reactome)
Personal tools